Dr Wen Hwa Lee, the Strategic Alliances Manager at the Structural Genomics Consortium (SGC), is interviewed about how the SGC is working to revolutionise the way we think about drug discovery.
As part of the Tropical MedicineGlobal Health Seminar, Professor Peter Horby provides a rapid update (now available online) about the spreading Zika virus epidemic.
A study by researchers at the Wellcome Trust Centre for Human Genetics has uncovered the key role played by a single gene in how groups of animals diverge to form new species.
A Blueprint article discusses how researchers from the Centre for Tropical Medicine and Global Health, including Professors Peter Horby and Trudie Lang, led the frontline research response against Ebola, and how Professor Adrian Hillled the search for a vaccine at the height of the crisis. Professor Hill will also be giving the 2016 Oxford London lecture next month.
To mark World Cancer Day, the Oxford Science Blog interviews Professor Colin Goding from the Ludwig Institute about how his work is helping change cancer treatment.
Professor Sir Peter Ratcliffe is one of the co-founders of the Phenomics Discovery initiative (PDi), which will be housed in the Target Discovery Institute. The PDi aims to build robust disease-relevant phenotypic assays to help identify new drug targets.
Dr George Busby from the Wellcome Trust Centre for Human Genetics explains how genetic studies reveal that humans have moved and mixed a lot more than previously thought.
Professor Trudie Lang highlights the potential dangers posed by the mosquito-borne Zika virus, urging the international community to learn from the Ebola epidemic to act sooner. In a detailed Q&A on the Oxford University science blog, she discusses efforts to build local research capacity to meet the next epidemic.
Researchers from the Oxford University Clinical Research Unit in Vietnam have completed what is probably the largest ever controlled trial of tuberculous meningitis. The study is published in the New England Journal of Medicine. Tuberculous meningitis is the most destructive form of the disease, with tube
Working with an interdisciplinary team, Jenner Institute researchers have helped devise a new technique to speed up the development of novel vaccines, by using a bacterial 'superglue' to produce customized candidate vaccines.
On 14 Dec, Mr Gilles Garachon, the French Ambassador to Thailand, arrived at Mae Sot in Thailand to present France\u2019s highest award, l'Ordre National de la L\u00e9gion d\u2019honneur, to Professor Fran\u00e7ois Nosten, Head of MORU\u2019s Shoklo Malaria Research Unit (SMRU). The award is in recognition of Professsor Nosten's work
Melioidosis, a difficult to diagnose deadly bacterial disease, is likely to be present in many more countries than previously thought, a new Nature Microbiology study from MORU researchers finds. The study predicts that melioidosis is present in 79 countries, including 34 that have never reported the disease.
Blood plasma from people who have survived Ebola may be one potential treatment for Ebola, as it may contain antibodies that likely helped survivors successfully fight off the disease. A study including Professor Peter Horby has now found that such treatment during an Ebola outbreak is feasible and safe.
Dr Kilian Huber, Principal Investigator for Chemical Biology, has been awarded the \u201cYoung Investigator Award of the German Pharmaceutical Society (DPhG-Stiftung/Horst-B\u00f6hme-Stiftung) 2015\u201d Please note the Society's press release is in German.
Researchers from the KEMRI Wellcome Trust programme in Kenya have uncovered some of the molecular processes through which some people appear to be naturally immune to malaria. Understanding these processes could help suggest new approaches to a malaria vaccine.
Dr Najib Rahman has led a study that challenges current guidelines that advocate the avoidance of nonsteroidal anti-inflammatory drugs (NSAIDs) and use of small chest tubes for a specific lung condition.
In a special Oxford Science Blog interview to mark World AIDS Day (1st December), Professor Lucy Dorrell discusses how the treatment of AIDS has changed over the years - and how future treatments are aiming to cure the disease.
The Ludwig Institute for Cancer Research has received a \u00a394,000 fundraising boost from the Masonic Samaritan Fund. Ludwig Cancer Research is pioneering efforts to find drugs to treat cancer as well as neurodegenerative diseases.
Dr Salima Sarah Nurmohamed has been awarded the John Goldman Fellowship for Future Science by the leukaemia research charity Leuka. The fellowship carries a grant of \u00a3100,000, and will support Dr Nurmohamed\u2019s project characterizing GATA2, a key transcriptional regulator, in blood development and leukaemia.
![\"The](\"https://www.tdi.ox.ac.uk/about/latest-news/the-definition-of-success/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n